The AJMC® Atopic Dermatitis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin condition that typically develops in early childhood.
June 30th 2024
Patients with atopic dermatitis, particularly males and those aged 40 to 59 years, have significantly higher rates of impaired mobility.
Develop a deeper understanding of the atopic dermatitis (AD) patient journey, explore topical therapies and treatment sequencing advancements, and gain insight regarding the payer’s perspective on AD therapies.
Topical Calcineurin Inhibitors for AD Not Associated With Cancer
Dupilumab Efficacy in AD Not Affected by Age of Disease Onset
Skin Biomarkers Found to Predict Development of Pediatric Atopic Dermatitis